The aim of this review paper is to highlight the clinical significance of these specific markers, i.e., TNF alpha and CEA, for the development of gastric cancer as well as for the risk of other inflammatory conditions and a possible correlation of other biomarkers like CA 72-4 in patients with gastric cancer. The gene discussed is TNF; the disease is gastric cancer.